158 related articles for article (PubMed ID: 37773302)
41. Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells.
Fani S; Kamalidehghan B; Lo KM; Hashim NM; Chow KM; Ahmadipour F
Drug Des Devel Ther; 2015; 9():6191-201. PubMed ID: 26648695
[TBL] [Abstract][Full Text] [Related]
42. Non-Benzoquinone Geldanamycin Analog, WK-88-1, Induces Apoptosis in Human Breast Cancer Cell Lines.
Zhao YR; Li HM; Zhu M; Li J; Ma T; Huo Q; Hong YS; Wu CZ
J Microbiol Biotechnol; 2018 Apr; 28(4):542-550. PubMed ID: 29618179
[TBL] [Abstract][Full Text] [Related]
43. Ameliorated
Joshi M; Bhatt P
Nanotechnology; 2024 May; 35(33):. PubMed ID: 38746972
[TBL] [Abstract][Full Text] [Related]
44. Anti-breast cancer potential of frullanolide from
Chimplee S; Graidist P; Srisawat T; Sukrong S; Bissanum R; Kanokwiroon K
Oncol Lett; 2019 Jun; 17(6):5283-5291. PubMed ID: 31186745
[TBL] [Abstract][Full Text] [Related]
45. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
[TBL] [Abstract][Full Text] [Related]
46. Differential anti-tumor activity of coriolus versicolor (Yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells.
Ho CY; Kim CF; Leung KN; Fung KP; Tse TF; Chan H; Lau CB
Cancer Biol Ther; 2005 Jun; 4(6):638-44. PubMed ID: 15908782
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines.
Attarde SS; Pandit SV
BMC Complement Altern Med; 2017 Nov; 17(1):503. PubMed ID: 29183371
[TBL] [Abstract][Full Text] [Related]
48. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
49. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
50. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive Analysis of the Chemical Composition and In Vitro Cytotoxic Mechanisms of Pallines Spinosa Flower and Leaf Essential Oils Against Breast Cancer Cells.
Saleh AM; Al-Qudah MA; Nasr A; Rizvi SA; Borai A; Daghistani M
Cell Physiol Biochem; 2017; 42(5):2043-2065. PubMed ID: 28803233
[TBL] [Abstract][Full Text] [Related]
52. Cytotoxic effect of sanguiin H-6 on MCF-7 and MDA-MB-231 human breast carcinoma cells.
Park EJ; Lee D; Baek SE; Kim KH; Kang KS; Jang TS; Lee HL; Song JH; Yoo JE
Bioorg Med Chem Lett; 2017 Sep; 27(18):4389-4392. PubMed ID: 28835347
[TBL] [Abstract][Full Text] [Related]
53. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
Ding T; Yang LJ; Zhang WD; Shen YH
J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778
[TBL] [Abstract][Full Text] [Related]
54. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
55. Cytotoxicity of Simvastatin in Human Breast Cancer MCF-7 and MDA-MB-231 Cell Lines.
Rezano A; Ridhayanti F; Rangkuti AR; Gunawan T; Winarno GNA; Wijaya I
Asian Pac J Cancer Prev; 2021 Feb; 22(S1):33-42. PubMed ID: 33576210
[TBL] [Abstract][Full Text] [Related]
56. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
[TBL] [Abstract][Full Text] [Related]
57. New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells.
Allan G; Ouadid-Ahidouch H; Sanchez-Fernandez EM; Risquez-Cuadro R; Fernandez JM; Ortiz-Mellet C; Ahidouch A
PLoS One; 2013; 8(10):e76411. PubMed ID: 24124558
[TBL] [Abstract][Full Text] [Related]
58. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238
[TBL] [Abstract][Full Text] [Related]
59. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
[TBL] [Abstract][Full Text] [Related]
60. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
